Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: A pilot study

Critical Care

Volumn 11, Issue 5, 2007, Pages

  de Pont, Anne Cornélie J M ^a   Hofstra, Jorrit Jan H ^a   Pik, Derk R ^b   Meijers, Joost C M ^a   Schultz, Marcus J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID; HEPARIN; ANTICOAGULANT AGENT; CHONDROITIN SULFATE; DERMATAN SULFATE; HEPARAN SULFATE;

ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; EXTRACORPOREAL CIRCULATION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; KIDNEY FAILURE; LOADING DRUG DOSE; MATHEMATICAL MODEL; MATHEMATICAL VARIABLE; PRIORITY JOURNAL; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; AGED; COHORT ANALYSIS; DOSE RESPONSE; FEMALE; HEMOFILTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; PILOT STUDY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; CHONDROITIN SULFATES; COHORT STUDIES; DERMATAN SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOFILTRATION; HEPARITIN SULFATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 36048982271     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6119     Document Type: Article

References (11)

1. Warkentin TE Greinacher A Heparin-induced thrombocytopenia: Recognition, treatment and prevention. The seventh ACCP Conference on antithrombotic and thrombolytic therapy Chest 2004, 126:311S-337S 10.1378/ chest.126.3_suppl.311S 15383477
2. Acostamadiedo JM Iyer UG Owen J Danaparoid sodium Expert Opin Pharmacother 2000, 1:803-814 10.1517/14656566.1.4.803 11249517
3. Schneider KS Elimination of danaparoid by means of filtration - determination of the elimination technique in saline, human albumin and human whole blood. Elimination von Danaparoid mittels Filtration - Bestimmung der Eliminationstechnik in physiologischer Kochsalzlösung, Humanalbumin und humanem Vollblut PhD thesis. Medizinische Fakultät, Albert-Ludwigs-Universität, Freiburg im Breisgau 2004
4. Hassell K The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy Chest 2005, 127: (2 Suppl)1S-8S 10.1378/chest.127.2_suppl.1S 15706025
5. Lindhoff-Last E Betz C Bauersachs R Use of a low molecular weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients Clin Appl Thromb Haemost 2001, 7:300-304
6. Lo GK Juhl D Warkentin TE Sigouin CS Eichler P Greinacher A Evaluation of pretest clinical score (4T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings J Thromb Haemost 2006, 4:759-765 10.1111/j.1538-7836.2006.01787.x 16634744
7. Ronco C Bellomo R Homel P Brendolan A Dan M Piccinni P La Greca G Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective, randomised trial Lancet 2000, 356: 26-30 10.1016/S0140-6736(00)02430-2 10892761
8. de Pont AC Oudemans-van Straaten HM Roozendaal KJ Zandstra DF Nadroparin versus dalteparin anticoagulation in high-volume continuous venovenous hemofiltration: A double-blind, randomized, crossover study Crit Care Med 2000, 28:421-425 10.1097/00003246-200002000-00022 10708177
9. Journois D Safran D Castelain MH Chanu D Drevillon C Barrier G Comparison of the antithrombotic effects of heparin, enoxaparin and prostacycline in continuous hemofiltration. [Comparaison des effets antithrombotiques de l'héparine, l'enoxaparine et la prostacycline au cours de l'hémofiltration continue] Ann Fr Anesth Reanim 1990, 9:331-337 2169213
10. Joannidis M Kountchev J Rauchenzauner M Schusterschitz N Ulmer H Mayr A Bellmann R Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: A randomized controlled crossover study Intensive Care Med 2007, 33:1571-1579 10.1007/ s00134-007-0719-7 17563874
11. Hirsh J Warkentin TE Shaughnessy SG Anand SS Halperin JL Raschke R Granger C Ohman EM Dalen JE Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety Chest 2001, 119: 64S-94S 10.1378/chest.119.1_suppl.64S 11157643